Risk of mortality in a cohort of patients newly diagnosed with chronic atrial fibrillation

被引：29

作者：

Ruigómez A. ^{[1
]}

Johansson S. ^{[2
,3
]}

Wallander M.-A. ^{[2
,4
]}

Rodríguez L.A.G. ^{[1
]}

机构：

[1] CEIFE, Madrid

[2] AstraZeneca, Mölndal

[3] Section of Preventive Cardiology, Göteborg University, Göteborg

[4] Dept. of Public Health/Caring Sci., Uppsala University, Uppsala

来源：

BMC Cardiovascular Disorders | / 2卷 / 1期

关键词：

Atrial Fibrillation; Mortality Risk; Index Date; Ischaemic Heart Disease; Disopyramide;

D O I：

10.1186/1471-2261-2-5

中图分类号：

学科分类号：

摘要：

Objective: To estimate the mortality rate of patients newly diagnosed with chronic atrial fibrillation (AF) and compare it with the one in the general population. To evaluate the role of comorbidity and other factors on the risk of dying among AF patients. Methods: We used the General Practice Research Database in the UK to perform a retrospective cohort study. We followed a cohort of chronic AF patiens (N = 1,035) and an age and sex matched cohort of 5,000 subjects sampled from the general population. We used all deceased AF patients as cases (n = 234) and the remaining AF patients as controls to perform a nested case-control analysis. We estimated mortality risk associated with AF using Cox regression. We computed mortality relative risks using logistic regression among AF patients. Results: During a mean follow-up of two years, 393 patients died in the general population cohort and 234 in the AF cohort. Adjusted relative risk of death in the cohort of AF was 2.5 (95%CI 2.1 - 3.0) compared to the general population. Among AF patients, mortality risk increased remarkably with advancing age. Smokers carried a relative risk of dying close to threefold. Ischaemic heart disease was the strongest clinical predictor of mortality with a RR of 3.0 (95% CI; 2.1-4.1). Current use of calcium channel blockers, warfarin and aspirin was associated with a decreased risk of mortality. Conclusions: Chronic AF is an important determinant of increased mortality. Major risk factors for mortality in the AF cohort were age, smoking and cardiovascular co-morbidity, in particular ischaemic heart disease. © 2002 Ruigómez et al; licensee BioMed Central Ltd.

引用

页数：7

共 21 条

[1]

Go A.S., Hylek E.M., Phillips K.A., Chang Y., Henault L.E., Selby J.V., Singer D.E., Prevalence of diagnosed atrial fibrillation in adults. National Implications for rhythm management and stroke prevention: The anticoagulation and risk factors in atrial fibrillation (ATRIA) Study, JAMA, 285, pp. 2370-2375, (2001)

[2]

Benjamin E.J., Wolf P.A., D'Agostino R.B., Silbershatz H., Kannel W.B., Levy D., Impact of atrial fibrillation on the risk of death: The Framingham Heart Study, Circulation, 98, 10, pp. 946-952, (1998)

[3]

Krahn A.D., Manfreda J., Tate R.B., Mathewson F.A., Cuddy T.E., The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba Follow-up study, Am. J. Med., 98, 5, pp. 476-484, (1995)

[4]

Ruigomez A., Johansson S., Wallander M.A., Garcia Rodriguez L.A., The incidence of chronic atrial fibrillation in general practice and its treatment pattern, J. Clin. Epidemiol., 55, pp. 358-363, (2002)

[5]

Benjamin E.J., Levy D., Vaziri S.M., D'Agostino R.B., Belanger A.J., Wolf P.A., Independent risks factors for atrial fibrillation in a population-based cohort: The Framingham Heart Study, JAMA, 271, pp. 840-844, (1994)

[6]

Humphries K.H., Kerr C.R., Connoly S.J., Klein G., Boone J.A., Green M., Sheldon R., Talajic M., Dorian P., Newman D., New-onset atrial fibrillation: Sex differences in presentation, treatment and outcome, Circulation, 103, 19, pp. 2365-2370, (2001)

[7]

Dries D.L., Exner D.V., Gersh B.J., Domanski M.J., Warclawiw M.A., Stevenson L.W., Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction, J. Am. Coll. Cardiol., 32, 3, pp. 695-703, (1998)

[8]

Laupacis A., Cuddy T.E., Prognosis of individuals with atrial fibrillation, Can. J. Cardiol., 12, (1996)

[9]

Wolf P.A., Mitchell J.B., Baker C.S., Kannel W.B., Dagostino R.B., Impact of atrial fibrillation on mortality, stroke, and medical costs, Arch. Intern. Med., 158, 3, pp. 229-234, (1998)

[10]

Scardi S., Mazzone C., Pandullo C., Goldstein D., Di Lenarda A., Chersevani D., Mortality and cause of death in patients with chronic non-rheumatic atrial fibrillation after two years follow-up, G. Ital. Cardiol., 29, 6, pp. 637-646, (1999)

← 1 2 3 →